• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 4 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 1 day ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 4 months 4 weeks ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 2 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 3 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

PROSPECTS

portrait of Prof. Matthias Mann

Prof. Matthias Mann

Scientific Coordinator of PROSPECTS, based at the Max Planck Institute of Biochemistry in Martinsried near Munich, Germany

Research field

Proteomics (large-scale study of proteins)

If you like this
If you want to know more
Research Profile

Who?

“PROSPECTS is a European flagship project in the proteomics field“, says Dr. Matthias Mann, Director of the Department of Proteomics and Signal Transduction at the Max Planck Institute in Germany. Mann and his team pioneered the application of a technique called “mass spectrometry” in biomedical research.

Why?

Proteins govern practically all biological processes. The proteome of healthy and diseased cells often differs. For instance, in neurodegenerative disorders like Huntington's disease, misfolded proteins aggregate. Identifying such proteome changes will improve our ability to diagnose and treat diseases facing European citizens.

What?

The complete protein repertoire of a human being is called the "proteome". Proteomics is the large-scale study of the structures and functions of proteins. PROSPECTS will develop new methods and instruments for proteomics research. The results will be available to the scientific community via public databases.

How?

The European funds allow the project to bring together leading experts in sophisticated technologies, including mass spectrometry, cryoelectron microscopy and cell imaging. These talented scientists have now joined forces to develop powerful new proteomics technologies and instruments for biomedical research.

A new generation of proteomics research

In the Picture
In the Picture
PROSPECTS website The Cell Biologist's Guide to Proteomics In Focus article 'Proteins rule!' PDF versionPDF version
Image credits

Background image: PROSPECTS

Portrait of the project coordinator: PROSPECTS

Timeline (in chronological order): PROSPECTS